Index trend and stocks in action July 17, 2018
Index trend and stocks in action July 17, 2018

Index trend and stocks in action July 17, 2018

Karan Dsij Article rating: 5.0

Monday’s session low (10,926) would be a crucial level for the coming session as this level is near about the May high of 10,929. However, a fall below this level would lead to a further decline up to the level of 10,879, which is 38.2 per cent retracement of the recent upmove, followed by 10,833 level, which is an important short-term moving average, i.e. 20-day EMA. Stocks in news: Adani Ports, BEML, Dilip Buildcon and BEL. 

Markets likely to open in the red amid negative global cues
Markets likely to open in the red amid negative global cues

Markets likely to open in the red amid negative global cues

Karan Dsij Article rating: 5.0

Indian equities are expected to open lower amid negative global cues. The Nifty 50 index future on the Singapore stock exchange is currently trading down by 10 points at 10,936.

India INX renames derivative contract
India INX renames derivative contract

India INX renames derivative contract

Shohini Nath Article rating: 5.0

India INX changes name of ‘S&P BSE SENSEX 50 Futures & Options contracts’ to ‘India 50 Futures & Options contracts’ 

IPO Analysis : TCNS Clothing Co.
IPO Analysis : TCNS Clothing Co.

IPO Analysis : TCNS Clothing Co.

Apurva Joshi Article rating: 4.3

TCNS Clothing Co. Ltd. is coming out with an IPO which will remain open for subscription from July 18 to July 20, 2018. The issue consists purely of Offer for Sale (OFS) worth Rs 1125.13 crore. Through this OFS, the company is offering 1,57,14,038 equity shares having face value of Rs 2 per share. The price band of the issue is Rs 714-716. The minimum lot size is 20 shares. Post allotment, the company will be listed on both BSE and NSE.

Suven Life Sciences receives product patents in Europe, South Korea
Suven Life Sciences receives product patents in Europe, South Korea

Suven Life Sciences receives product patents in Europe, South Korea

Nidhi Jani Article rating: 4.3

These granted patents are corresponding to the New chemical entity (NCE) for the treatment of disorders associated with neurodegenerative diseases including Alzheimer’s, attention deficient hyperactivity disorder (ADHD), schizophrenia, Huntington’s disease and Parkinson’s.

Minda acquires iSYS RTS, stock shows resistance at breakout levels
Minda acquires iSYS RTS, stock shows resistance at breakout levels

Minda acquires iSYS RTS, stock shows resistance at breakout levels

Bhagyashree Vivarekar Article rating: 4.0

The company announced the acquisition of iSYS RTS, a Germany-based firm. The stock of Minda Industries opened on a positive note and hit a high of 427 and is currently trading marginally up with 0.4 per cent gains at 421 levels at 12:46 hours. 

Aurobindo Pharma widens its presence in Europe
Aurobindo Pharma widens its presence in Europe

Aurobindo Pharma widens its presence in Europe

Shohini Nath Article rating: 5.0

Aurobindo Pharama Limited's wholly-owned step-down subsidiary, Agile Pharma B.V (Netherlands) has entered into an agreement to acquire Apotex International Inc’s commercial operations in five European countries for 74 million euro. 

RSS
First28882889289028912893289528962897Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR